Min Xiao

8PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Haematological tumoursTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 30, 2025
CD5 ablation enhances persistence and antitumor potency of engineered T cells by mitigating exhaustion and promoting cytotoxicity.

Jia Wu, Jiali Cheng, Li Zhu

|Dec 11, 2024
Development and validation of a deep learning model for morphological assessment of myeloproliferative neoplasms using clinical data and digital pathology.

Rong Wang, Zhongxun Shi, Yuan Zhang

|Apr 05, 2024
Monozygotic Twins with MAGT1 Deficiency and Epstein-Barr virus-positive Classic Hodgkin Lymphoma Receiving anti-CD30 CAR T-cell Immunotherapy: A case Report.

Jiachen Wang, Mi Zhou, Jianfeng Zhou

|Mar 08, 2024
A single-centre, real-world study of BTK inhibitors for the initial treatment of MYD88mut /CD79Bmut diffuse large B-cell lymphoma.

Ting Deng, Shiyuan Zhang, Min Xiao

|Oct 24, 2023
Transformation to diffuse large B-cell lymphoma and its impact on survival in patients with marginal zone lymphoma: A population-based study.

Yu Du, Ying Wang, Qinlu Li

|May 05, 2023
CD137 deficiency because of two novel biallelic TNFRSF9 mutations in a patient presenting with severe EBV-associated lymphoproliferative disease.

Kefeng Shen, Jiachen Wang, Kuangguo Zhou

Pageof 2

Frequent Collaborators

3 joint publications

Liang Huang

1 joint publications

Chunrui Li

1 joint publications

Zhe Li

1 joint publications

Kefeng Shen